Lantern Pharma, Inc. (LTRN)
0.6354
-0.01
(-0.83%)
USD |
NASDAQ |
Oct 23, 16:00
0.622
-0.01
(-2.11%)
After-Hours: 20:00
Lantern Pharma Market Cap : 8.107M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.107M |
| October 22, 2026 | 8.175M |
| October 21, 2026 | 8.734M |
| October 20, 2026 | 8.375M |
| October 19, 2026 | 8.182M |
| October 16, 2026 | 8.528M |
| October 15, 2026 | 8.508M |
| October 14, 2026 | 8.587M |
| October 13, 2026 | 9.068M |
| October 12, 2026 | 9.404M |
| October 09, 2026 | 10.37M |
| October 08, 2026 | 10.59M |
| October 07, 2026 | 11.61M |
| October 06, 2026 | 12.17M |
| October 05, 2026 | 11.99M |
| October 02, 2026 | 10.97M |
| October 01, 2026 | 12.76M |
| September 30, 2026 | 12.89M |
| September 29, 2026 | 13.84M |
| September 28, 2026 | 13.91M |
| September 25, 2026 | 15.57M |
| September 24, 2026 | 15.44M |
| September 23, 2026 | 17.74M |
| September 22, 2026 | 17.35M |
| September 21, 2026 | 19.14M |
| Date | Value |
|---|---|
| September 18, 2026 | 19.78M |
| September 17, 2026 | 21.82M |
| September 16, 2026 | 24.63M |
| September 15, 2026 | 21.69M |
| September 14, 2026 | 21.82M |
| September 11, 2026 | 21.82M |
| September 10, 2026 | 22.46M |
| September 09, 2026 | 22.58M |
| September 08, 2026 | 23.48M |
| September 04, 2026 | 24.31M |
| September 03, 2026 | 23.86M |
| September 02, 2026 | 24.63M |
| September 01, 2026 | 25.77M |
| August 31, 2026 | 25.90M |
| August 28, 2026 | 26.41M |
| August 27, 2026 | 27.56M |
| August 26, 2026 | 27.81M |
| August 25, 2026 | 27.81M |
| August 24, 2026 | 26.92M |
| August 21, 2026 | 29.86M |
| August 20, 2026 | 29.22M |
| August 19, 2026 | 31.77M |
| August 18, 2026 | 32.15M |
| August 17, 2026 | 33.17M |
| August 14, 2026 | 33.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| Price | 0.6354 |
| Earnings Yield | -253.8% |